Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03554629 · ClinicalTrials.gov registry record · NA
A Comparison of Capnography Sampling Lines
A NA study of Capnography, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03554629: Completed NA study of Capnography, sponsored by Medtronic - MITG.
NCT03554629 is a NA study of Capnography that has completed, run by Medtronic - MITG. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03554629, a NA study of Capnography, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the performance of eight (8) cleared capnography carbon dioxide (CO2) sampling filterlines during patient simulated scripted activities when connected to a Medtronic (MDT) dual parameter monitor.
Primary Outcome
Comparison of measured end-tidal CO2 (EtCO2), Rebreathing as measured by fractional inspiratory CO2 (FiCO2) as a function the activity for 8 different CCSF designs tested on 23 subjects with supplemental O2 at 5lmp for four activities. Device data collected a 20Hz (20 data points/second) for the 3 hours of enrollment. Participants lateral lying with head on a pillow with supplemental O2 during each nasal only or open mouth breathing at respiration rate of 6 and 24.
Conditions Studied
Interventions
- DEVICE Capnography CO2 cannula sampling Flexiterline (CCSF) designs with supplemental O2
Study Locations (1)
Colorado
- Clinimark LLC - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2020-09-15 |
| Phase | NA |
What the finished NCT03554629 record still lists
NCT03554629 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Capnography appearing as the primary indexed condition, and to 1 intervention - of which Capnography CO2 cannula sampling Flexiterline (CCSF) designs with supplemental O2 is the first listed.
NCT03554629 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03554629 about?
NCT03554629 is a clinical study titled "A Comparison of Capnography Sampling Lines". This study evaluates the performance of eight (8) cleared capnography carbon dioxide (CO2) sampling filterlines during patient simulated scripted activities when connected to a Medtronic (MDT) dual parameter monitor.
What is the current status of trial NCT03554629?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-05-01. Estimated completion is 2020-09-15.
What conditions does trial NCT03554629 study?
This clinical trial studies the following conditions: Capnography.
What interventions are being tested in trial NCT03554629?
The interventions under investigation include: Capnography CO2 cannula sampling Flexiterline (CCSF) designs with supplemental O2 (DEVICE).
Who is sponsoring clinical trial NCT03554629?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03554629 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03554629's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI